As Forbes reports, if you've watched the nightly news or sports over the last decade, you've likely seen a commercial for testosterone medicaitons, like AndroGel or Axiron. Thanks to this advertising, testosterone prescriptions have risen 10-fold in the last decade.
According to Dr. Thomas Perls, a professor at Boston University and geriatrician at Boston Medical Center, testosterone makers "market the idea that men go through something similar to menopause, where they have these marked declines in testosterone and all these symptoms that we normally attribute to aging." The manufacturer's sales pitch was that "if we give you testosterone, it will reverse the problem." According to Dr. Perls, "It was a wildly successful ad campaign. We consider it to be disease mongering."
An article by Dr. Perls and Dr. David Handelsman comes just weeks after the FDA issued new lableing changes to clarify that testosterone should only be used by patients with hypogonadism. However, Dr. Perls and Dr. Handelsman argue this isn't enough. They believe that the FDA should team up with the Federal Trade Commission and ban testosterone advertising for made-up conditions like Low T or andropause. They're further arguing that the FDA should require physicians to demonstrate that any patient prescribed testosterone actually has a disease that needs to be treated.
Their recommendation makes sense in light of the serious risks associated with testosterone use: heart attack, stroke, pulmonary embolism, deep vein thrombosis, blood clots and death.
If you or a loved one suffered a heart attack, stroke, blood clot or death after taking a testosterone medication, like AndroGel, please call our experienced AndroGel attorneys at (888) 606-5297 for a free consultation about your potential testosterone lawsuit.